Jane Street Group, LLC Krystal Biotech, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 18,181 shares of KRYS stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,181

Previous 77,832 76.64%

Holding current value

$3 Million

Previous $14.3 Million 76.87%

% of portfolio

0.0%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$174.7 - $213.66 $10.4 Million - $12.7 Million	-59,651 Reduced 76.64%	18,181 $3.31 Million
Q2 2024 Aug 14, 2024	SELL	$153.12 - $183.64 $2.44 Million - $2.92 Million	-15,913 Reduced 16.97%	77,832 $14.3 Million
Q1 2024 May 15, 2024	BUY	$108.01 - $179.35 $4.66 Million - $7.73 Million	43,127 Added 85.2%	93,745 $16.7 Million
Q4 2023 Feb 14, 2024	SELL	$96.0 - $128.29 $2.35 Million - $3.14 Million	-24,508 Reduced 32.62%	50,618 $6.28 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $6.3 Million - $7.56 Million	58,071 Added 340.49%	75,126 $8.71 Million
Q2 2023 Aug 14, 2023	SELL	$78.48 - $130.32 $553,362 - $918,886	-7,051 Reduced 29.25%	17,055 $2 Million
Q1 2023 May 15, 2023	BUY	$72.39 - $84.27 $1.75 Million - $2.03 Million	24,106 New	24,106 $1.93 Million
Q2 2022 Aug 16, 2022	SELL	$48.93 - $73.47 $773,974 - $1.16 Million	-15,818 Reduced 77.82%	4,509 $296,000
Q1 2022 May 17, 2022	SELL	$51.99 - $72.11 $382,490 - $530,513	-7,357 Reduced 26.57%	20,327 $1.35 Million
Q4 2021 Feb 15, 2022	BUY	$39.81 - $88.24 $1.1 Million - $2.44 Million	27,684 New	27,684 $1.94 Million
Q1 2021 May 18, 2021	SELL	$59.42 - $85.46 $618,324 - $889,296	-10,406 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$40.64 - $61.38 $422,899 - $638,720	10,406 New	10,406 $624,000
Q4 2019 Feb 14, 2020	SELL	$33.17 - $65.23 $230,166 - $452,630	-6,939 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$34.72 - $51.3 $240,922 - $355,970	6,939 New	6,939 $241,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.23B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Krystal Biotech, Inc. Transaction History